CR-10

The name **CR-10** is a non-specific designation typically used in the pharmaceutical industry to denote a **10 mg controlled-release (CR)** or **extended-release** formulation of various active pharmaceutical ingredients. In clinical and commercial contexts, it most frequently refers to 10 mg sustained-release versions of medications such as **carvedilol** (a non-selective beta-blocker used for hypertension and heart failure), **norethisterone** (a synthetic progestin used for menstrual disorders), or **nifedipine** (a calcium channel blocker used for hypertension and angina). Because the term describes a dosage strength and delivery mechanism rather than a unique chemical entity, its specific therapeutic application and mechanism of action depend entirely on the underlying active ingredient. In the context of medical research, "CR10" may also refer to the **Concentration Ratio** of the top 10 companies in a market or a **Complete Response** rate of 10% in clinical trials.